<p>2017 年に設立された Ouyi OKX は、世界をリードするデジタル通貨取引プラットフォーム、分散型エコロジカル アグリゲーション プラットフォーム Web3 ウォレットを備え、業界をリードする取引システムである統合取引アカウントを作成しました。ユーザーは、CeFi と Web3 の資産を同時に簡単に管理できます。 Ouyi は、ビットコイン、イーサリアム、その他のデジタル通貨資産のスポット、デリバティブ取引、金融商品などのサービスを世界中のユーザーに提供し、ユーザーが暗号化資産を便利かつ迅速に管理および投資できるように支援します。 Ouyi Web3 ウォレットは最も包括的な分散型異種マルチチェーン ウォレットであり、60 以上のパブリック チェーン、組み込みウォレット、取引、コイン獲得、NFT マーケット、Dapp 探索の 5 つの主要セクションをサポートしており、ユーザーが Web3 の世界を体験するのに便利です。ワンストップで。 Ouyi Blockdream Ventures は、暗号化経済の繁栄を促進するために、世界中の何百ものブロックチェーン プロジェクトに投資してきました。今後、OuyiはWeb3.0、Metaverse、DeFi、GameFiなどの分野に発展していきます。現在、Ouyi のユーザーは世界中で 5,000 万人を超え、180 以上の国と地域をカバーしています。米国、シンガポール、マルタ、ドバイ、その他世界中の地域にオフィスを構えています。 Ouyi は今後も安全、安定、信頼できるデジタル通貨資産取引をユーザーに提供し、ユーザーに Web3 世界への安全かつ豊富な直接アクセスを提供していきます。</p>

AbbVie Inc.

AbbVie is a global biopharmaceutical company dedicated to the discovery, development, manufacturing, and commercialization of advanced therapeutics. Its extensive portfolio spans multiple key therapeutic areas: Immunology and inflammation: Key products include HUMIRA, an injectable therapy for autoimmune and gastrointestinal diseases; SKYRIZI, for moderate to severe plaque psoriasis in adults; and RINVOQ, a JAK inhibitor for moderate to severe active rheumatoid arthritis in adults. Oncology and hematology: For blood cancers, AbbVie offers IMBRUVICA and VENCLEXTA (a BCL-2 inhibitor), both indicated for adult patients with chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL). Virology: MAVYRET provides treatment options for adults infected with chronic HCV genotypes 1–6. Gastroenterology and endocrinology: The company offers CREON replacement therapy for exocrine pancreatic insufficiency and Synthroid for hypothyroidism. Linzess/Constella helps treat irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation. Women's health and urology: Lupron serves as palliative treatment for anemia caused by advanced prostate cancer, endometriosis, central precocious puberty, and uterine fibroids. ORILISSA is a non-peptide small molecule GnRH antagonist designed specifically for women with moderate to severe endometriosis-related pain. Neurology: AbbVie provides Duopa and Duodopa, a levodopa-carbidopa intestinal gel for Parkinson’s disease, and Ubrelvy for treating migraines in adults (with or without aura). Botulinum toxin formulations are also part of its product offerings. Ophthalmology: Its ophthalmic care includes Lumigan/Ganfort (bimatoprost ophthalmic solution) and Alphagan/Combian (an alpha-adrenergic agonist), both aimed at reducing elevated intraocular pressure in patients with open-angle glaucoma (OAG) or ocular hypertension. Restasis is a calcineurin inhibitor immunosuppressant that promotes tear production, along with other specialized ophthalmic care products. AbbVie also engages in research collaborations, including one with Dragonfly Therapeutics, Inc. The company was founded in 2012 and is headquartered in North Chicago, Illinois.

 () Intro

American Bitcoin Says Q3 Net Income Reached $126M as BTC Reserve Grew

https://blockchainreporter.net/wp-content/uploads/2025/03/bitcoin-mining2-6.webp

MARA Sold 13,597 Bitcoin at $81,039 to Retire $750 Million of BTC-Backed Debt

highest

Duration

lowest

facebook

twitter

reddit

weibo

github

Please note that you are going to a third-party website. This website is not controlled by MyToken and you are responsible for your own operation risks.

MyToken (www.mytokencap.com) is dedicated to meeting users' comprehensive needs for global digital asset market data and news, and is one of the most influential digital asset market websites in the industry. We strive to provide the best one-stop investment experience for global users, presenting valuable content, news, and social experiences, as well as integrating more in-depth investment tools.

About Us - MyToken

What is MyToken?

Strategy Trading

On-chain Monitoring

The Future is Here

Learn about MyToken

{{name}} Price_{{symbol}} Today’s Market_{{name}} K-line Chart - MyToken

MyToken provides global cryptocurrency users with the latest {{name}} price, {{name}} today's market, {{name}} K-line trend chart, trading platforms, as well as {{name}} news, calendar events, holding changes, overall market trend, trading pair transaction proportion, market cap ranking trend chart

{{exchange}}{{name}} Price_{{symbol}} Today's Market_{{name}} K-line Trend - MyToken

Name

Currently, fund inflows are less than outflows {{compare}} outflow

Future market may have a {{judge}} possibility

The current market strength is relatively {{value}}, please control risks reasonably

The short-term trend has not yet formed a consensus, it is recommended to wait and observe until the market becomes clear

From a technical perspective, the major trend has not yet formed a consensus

The short-term market is in a {{value}} trend

From a technical perspective, the overall market direction is {{value}}

Based on multiple indicators, the current market trend at the {{time}} level is {{name}}

MyToken provides a comprehensive analysis of the cryptocurrency derivatives market, offering real-time price updates, open interest, and trading volume rankings to help you stay informed on digital asset market trends.

Providing {{pairs}} {{type}} {{exchange_name}} contract prices, trend charts, long/short ratios, liquidation data, funding rates, and more.

{{pairs}} {{type}} {{exchange_name}} Contract Price Chart - MyToken

Crypto Derivatives Market Overview: Real-Time Prices & Trading Insights | MyToken

Current Open Interest/24h Change

BTC 4H Long-Short Ratio

Token Liquidations

Exchange Liquidations

Total Liquidations

Long

Short

Liquidation

Liquidation Information

Liquidation Heatmap

Real-time Liquidation

Market

Derivatives Market Data

Futures Market

Funding Rate Data

Highest Funding Rate

Lowest Funding Rate

Global Liquidation

BTC Global Open Interest

BTC Open Interest on Exchanges

Top Open Interest Losers

Top Open Interest Gainers

Total Open Interest

Open Interest Trend

The statistics reflect the ratio of long and short positions actively traded within a 4-hour period.

Cryptocurrency Funding Rate, Bitcoin Funding Rate, Binance Funding Rate, OKX Funding Rate, Bybit Funding Rate, Perpetual Contract Funding Rate, Real-time Funding Rate Data, Funding Rate Comparison

Real-time Cryptocurrency Funding Rate Comparison, Bitcoin Funding Rate | Binance, OKX, Bybit Perpetual Contract Funding Rate Data | MyToken

By applying to become an order recipient and binding the trading API, you agree to the following disclaimer:

1. API Usage Responsibility: The individual operator acknowledges and confirms that binding the trading API is for executing contract trades. All transactions executed via the API are independent of the order recipient’s decisions, and the order recipient assumes full responsibility for the trading results.

2. Security: The order recipient is responsible for safeguarding their API key. Unauthorized access or use may result in financial loss. Brokers must immediately notify the platform in writing of any unauthorized use.

3. Trading Risks: Using the trading API involves market risks, including but not limited to price fluctuations and slippage. Leaders should independently assess market risks. Individual members should also independently assess market risks, and the platform bears no responsibility for losses caused by market fluctuations.

4. Technical Issues: The use of the trading API may be affected by technical issues, including but not limited to system failures and network interruptions. The platform is not responsible for losses resulting from technical issues.

5. API Key Protection: The order recipient must properly safeguard their API key and not share it with any third party. Any loss caused by the leakage of the API key shall be borne by the order recipient.

6. Compliance: Leaders using the API must comply with all applicable laws and regulations. Violations may result in the termination of the order recipient’s qualification.

7. API Privileges: Leaders acknowledge and agree that the privileges granted by API binding will allow contract trading execution. The platform is not responsible for losses caused by the improper use of API privileges.

8. Disclaimer Changes: The platform reserves the right to modify the disclaimer at any time. Changes will be notified by the platform. By continuing to use the API, the order recipient agrees to any modifications to the disclaimer.

I have read, understood, and agreed to all the terms of the above disclaimer.

Top 100 Cryptocurrencies by Market Cap

Global Cryptocurrency Market Cap

Increased in the Last Day

Crypto Futures Market

24h Futures Trading Volume

Decreased Yesterday

Rising

MyToken - Your Expert in Digital Asset Market Data and Analysis. Providing the latest Bitcoin and cryptocurrency price trends, comprehensive on-chain data insights, and rich market analysis tools to help you stay ahead in the crypto market.

[Real-Time Update] Bitcoin & Crypto Market Price Trends and On-Chain Analysis - MyToken Market Insights

MyToken offers a comprehensive set of cryptocurrency analysis tools, covering real-time price updates, market trend analysis, and the latest crypto data. A one-stop solution to help you deeply understand and navigate the digital asset market.

AbbVie Inc.

XABBV